Alpha Teknova Inc (TKNO)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $516.43M
Last updated: Nov 17, 2026 at 11:06 AM ET
Alpha Teknova Inc (TKNO) Stock Forecast
Analysts expect Alpha Teknova (TKNO) to earn -$0.23 per share in the fiscal year ending Dec 31, 2026, on revenue of $46.92M. Of 8 analysts, 7 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 8 ratings average 2.13, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 88% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 7 | 87.5% |
| Hold | 1 | 12.5% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 8
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 14.7%.
- Fiscal year ending Dec 31, 2026
- -$0.23
- EPS consensus, revenue $46.92M
- Fiscal year ending Dec 31, 2027
- -$0.14
- EPS consensus, revenue $53.81M
- Next report
- Feb 24, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.23 | -$0.23 to -$0.23 | 1 | $46.92M | $46.10M to $47.50M | 8 |
| Dec 31, 2027 | -$0.14 | -$0.14 to -$0.14 | 1 | $53.81M | $52.50M to $55.00M | 8 |
Quarterly Estimates
The EPS consensus rises from -$0.08 for the quarter ending Dec 31, 2026 to -$0.07 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.08 | -$0.09 to -$0.07 | 10 | $11.29M | $10.41M to $12.07M | 9 |
| Mar 31, 2027 | -$0.07 | -$0.08 to -$0.05 | 6 | $12.40M | $11.70M to $12.86M | 6 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 2 upward and 0 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 0 | 0 |
| Quarter ending Mar 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$0.24.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.23 | N/A | -$0.24 | -$0.24 | -$0.24 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.14 | -$0.19 | -$0.19 | -$0.19 | -$0.19 | N/A |
| Quarter ending Mar 31, 2027 | -$0.07 | -$0.07 | -$0.07 | -$0.08 | -$0.08 | N/A |
Frequently Asked Questions About TKNO
What is the TKNO stock forecast?
Consensus analyst estimates put Alpha Teknova's EPS at -$0.23 for the fiscal year ending Dec 31, 2026, on revenue of $46.92M. The consensus rating from 8 analysts is Buy.
How do analysts rate TKNO stock?
Of 8 analysts covering Alpha Teknova, 0 rate it Strong Buy, 7 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from TKNO next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.23, with estimates from -$0.23 to -$0.23 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.14, with estimates from -$0.14 to -$0.14 from 1 analyst.
What revenue do analysts expect from Alpha Teknova next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $46.92M, with estimates from $46.10M to $47.50M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $53.81M, with estimates from $52.50M to $55.00M.
How many analysts cover TKNO?
8 analysts rate Alpha Teknova stock, and 1 analyst estimates its EPS for the fiscal year ending Dec 31, 2026.
TKNO pages: Overview, Earnings, Forecast, Financials, Competitors